Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

X4 Pharmaceuticals

Clinical trials sponsored by X4 Pharmaceuticals, explained in plain language.

X4 Pharmaceuticals XFOR NASDAQ

A biopharmaceutical company focused on developing therapies for rare immune system diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Completed 2

New drug aims to boost immune cells in rare blood disorder

Disease control Recruiting now

This Phase 3 study tests whether the drug mavorixafor can reduce serious infections and increase neutrophil levels in people with chronic neutropenia—a condition where the body doesn't make enough infection-fighting white blood cells. About 176 participants will receive either ma…

Phase: PHASE3 • Sponsor: X4 Pharmaceuticals • Aim: Disease control

Last updated Aug 08, 2026 00:03 UTC